Amy Moss Trombly is Chief Executive Officer of Sonoma Pharmaceuticals, Inc.. Currently has a direct ownership of 153,586 shares of SNOA, which is worth approximately $393,180. The most recent transaction as insider was on Jun 20, 2024, when has been sold 53,586 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 154K
0% 3M change
28.11% 12M change
Total Value Held $393,180

Amy Moss Trombly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2024
BUY
Grant, award, or other acquisition
-
53,586 Added 25.87%
153,586 Common Stock, $0.0001 ...
Jun 30 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 31.88%
213,648 Common Stock, $0.0001 ...
AMT

Amy Moss Trombly

Chief Executive Officer
Woodstock, GA

Track Institutional and Insider Activities on SNOA

Follow Sonoma Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNOA shares.

Notify only if

Insider Trading

Get notified when an Sonoma Pharmaceuticals, Inc. insider buys or sells SNOA shares.

Notify only if

News

Receive news related to Sonoma Pharmaceuticals, Inc.

Track Activities on SNOA